Clinical Trial Update: ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of ALIMTA (pemetrexed) in patients with locally advanced or metastatic cancer has completed, sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Alimta (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastases, Cancer | Phase 1 | Status: COMPLETED